SCHEMBL31095098

SCHEMBL31095098

CN(C)C(=O)C1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3C(=O)C[C@]12C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINA6 P08185 4/20 0.82
▸ FNTA P49354 1/20 0.67
▸ FNTB P49356 1/20 0.67
▸ SMN1; SMN2 Q16637 7/20 0.59
▸ LMNA P02545 5/20 0.59
▸ POLB P06746 1/20 0.59
▸ CYP3A4 P08684 5/20 0.59
▸ ALDH1A1 P00352 5/20 0.59
▸ TSHR P16473 3/20 0.59
▸ MAPT P10636 3/20 0.59
▸ MAPK1 P28482 3/20 0.59
▸ SHBG P04278 3/20 0.59
▸ CYP2C9 P11712 2/20 0.59
▸ HIF1A Q16665 2/20 0.59
▸ NR3C2 P08235 2/20 0.59
▸ NR3C1 P04150 2/20 0.59
▸ PMP22 Q01453 2/20 0.59
▸ ABCB11 O95342 2/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ KDM4E B2RXH2 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15904593 0.90 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL14420894 0.90 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL14525642 0.90 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL668966 0.90 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL15920543 0.90 SERPINA6 (1.00) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL9348234 0.89 SERPINA6 (0.85) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL18927106 0.89 SERPINA6 (0.85) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL9348241 0.89 SERPINA6 (0.85) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL6347180 0.88 SERPINA6 (0.84) SERPINA6FNTAFNTBSMN1; SMN2LMNA
SCHEMBL5497592 0.86 SERPINA6 (0.80) SERPINA6FNTAFNTBSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240270786-A1 STEROID COMPOUNDS EPIRIUM BIO INC (US) 2024-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240270786-A1 STEROID COMPOUNDS NR5A1, NR3C2, CYP17A1 SERPINA6 46/4885FNTA 278/4885FNTB 744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback